These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 2940265)
1. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. Faaber P; Rijke TP; van de Putte LB; Capel PJ; Berden JH J Clin Invest; 1986 Jun; 77(6):1824-30. PubMed ID: 2940265 [TBL] [Abstract][Full Text] [Related]
2. Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis? Berden JH; Termaat RM; Brinkman K; Smeenk RJ; Swaak AJ; Faaber P; Assmann K; van de Heuvel LP; Veerkamp JH Nephrologie; 1989; 10(3):127-32. PubMed ID: 2532712 [TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti-DNA and anti-heparan sulfate reactivity: a longitudinal study in NZB/W F1 mice. Hylkema MN; van Bruggen MC; van de Lagemaat R; Kramers K; Berden JH; Smeenk RJ J Autoimmun; 1996 Feb; 9(1):41-50. PubMed ID: 8845053 [TBL] [Abstract][Full Text] [Related]
4. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974 [TBL] [Abstract][Full Text] [Related]
5. Induction of systemic lupus erythematosus-like disease in mice by immunization with heparan sulfate. Ofosu-Appiah W; Sfeir G; Viti D; Burashnikova E Cell Immunol; 1998 Jan; 183(1):22-31. PubMed ID: 9578716 [TBL] [Abstract][Full Text] [Related]
6. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate. van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Berden JH Lab Invest; 1991 Sep; 65(3):287-97. PubMed ID: 1890809 [TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007 [TBL] [Abstract][Full Text] [Related]
8. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. Suzuki N; Harada T; Mizushima Y; Sakane T J Immunol; 1993 Jul; 151(2):1128-36. PubMed ID: 8335894 [TBL] [Abstract][Full Text] [Related]
12. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. Kramers C; Hylkema MN; van Bruggen MC; van de Lagemaat R; Dijkman HB; Assmann KJ; Smeenk RJ; Berden JH J Clin Invest; 1994 Aug; 94(2):568-77. PubMed ID: 8040312 [TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of anti-ssDNA antibodies with heparan sulfate in patients with type I diabetes mellitus. Triolo G; Giardina E; Scarantino G; Seddio G; Cardella F; Meli F; Bompiani G Diabetes; 1989 Jun; 38(6):718-22. PubMed ID: 2524415 [TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. Termaat RM; Brinkman K; van Gompel F; van den Heuvel LP; Veerkamp JH; Smeenk RJ; Berden JH J Autoimmun; 1990 Oct; 3(5):531-45. PubMed ID: 2252523 [TBL] [Abstract][Full Text] [Related]
15. Glomerular injury induced by antibodies against heparan sulfate proteoglycan (HSPG) derived from PYS 2 cells. Yoshida F; Matsuo S; Hiramatsu T; Okura T; Yuzawa Y; Watanabe Y; Sakamoto N; Matsuo S Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):135-43. PubMed ID: 2525633 [TBL] [Abstract][Full Text] [Related]
16. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis. van Bruggen MC; Kramers K; Hylkema MN; van den Born J; Bakker MA; Assmann KJ; Smeenk RJ; Berden JH Am J Pathol; 1995 Mar; 146(3):753-63. PubMed ID: 7534044 [TBL] [Abstract][Full Text] [Related]
17. Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis. Kim HJ; Hong YH; Kim YJ; Kim HS; Park JW; Do JY; Kim KJ; Bae SW; Kim CW; Lee CK Lupus; 2017 Jul; 26(8):815-824. PubMed ID: 28420046 [TBL] [Abstract][Full Text] [Related]
18. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus. Eivazova ER; McDonnell JM; Sutton BJ; Staines NA Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885 [TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes. Shibata S; Sasaki T; Harpel P; Fillit H Clin Immunol Immunopathol; 1994 Feb; 70(2):114-23. PubMed ID: 8299226 [TBL] [Abstract][Full Text] [Related]
20. Development of canine systemic lupus erythematosus model. Choi E; Shin I; Youn H; Lee C J Vet Med A Physiol Pathol Clin Med; 2004; 51(7-8):375-83. PubMed ID: 15533123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]